Phenylazomethine Dendrimers
FULL PAPER
Synthesis of C12DPAG1: OH-DPAG1 (57 mg, 0.11 mmol), 1-iododode-
cane (211 mg, 0.711 mmol), and K2CO3 (920 mg) were placed in a round-
bottomed flask, and DMF (5 mL) was added. The reaction mixture was
heated in an oil bath at 908C. The color of the reaction mixture turned
from yellow to orange. After 14 h, the reaction mixture was filtered and
concentrated. C12DPAG1 was isolated by silica gel column chromatogra-
phy (chloroform/ethyl acetate/hexane 3:1:3) and preparative-scale GPC
(90 mg, 0.18 mmol, 68%). 1H NMR (400 MHz, CDCl3, 258C, TMS): d=
7.64 (d, J=8.3 Hz, 4H), 6.98 (d, J=8.8 Hz, 4H), 6.87 (d, J=8.8 Hz, 4H),
6.73 (d, J=8.3 Hz, 4H), 6.52 (s, 4H), 3.99 (t, J=6.3 Hz, 4H), 3.94 (t, J=
6.6 Hz , 4H), 1.78 (t, J=6.3 Hz, 8H), 1.45–1.43 (m, 8H), 1.28–1.25 (m,
64H), 0.88 ppm (t, J=6.1 Hz, 12H); 13C NMR (100 MHz, CDCl3, 258C,
TMS): d=161.1, 159.1, 147.0, 132.9, 132.2, 131.4, 131.0, 128.4, 121.7, 113.9,
113.6, 68.1, 67.9, 31.9, 29.66, 29.63, 29.61, 29.58, 29.55, 29.43, 29.36, 29.33,
29.3, 29.2, 26.1, 26.0, 22.7, 14.1 ppm; MALDI-TOF MS: m/z: 1174.2
[M+H]+; elemental analysis calcd (%) for C80 H120N2O4: C 81.86, H
10.30, N 2.39; found: C 81.74, H 10.37, N 2.28.
(100 MHz, CDCl3, 258C, TMS): d=168.5, 167.9, 161.3, 159.4, 155.6,
152.4, 132.3, 132.2, 131.3, 131.2, 130.8, 130.2, 120.7, 113.9, 113.7, 113.5,
68.2, 68.0, 32.0, 29.7, 29.68, 29.65, 29.62, 29.47, 29.44, 29.40, 29.2, 26.13,
26.07, 22.7, 14.2 ppm; MALDI-TOF MS: m/z: 2732.2 [M+H]+; elemental
analysis calcd (%) for C187H256N6O9: C 82.21, H 9.44, N 3.08; found: C
82.65, H 9.68, N 3.20.
Synthesis of C12DPAG4: C12DPAG3on (599 mg, 99.4 mmol), NH2-
DPAG1 (13.6 mg, 27.5 mmol), and DABCO (2.00 g, 18.2 mmol) were
placed in a round-bottomed flask equipped with a three-necked adapter
(reflux condenser, dropping funnel, rubber septa seal), then dissolved in
chlorobenzene (50 mL). Under an N2 atmosphere, the reaction mixture
was heated in an oil bath at 1208C, then chlorobenzene (5 mL) and tita-
nium(IV) tetrachloride (0.5 mL, 4.56 mmol) were added by using an ad-
dition funnel. The titanium(IV) tetrachloride solution was added drop-
wise. After reacting for 12 h, the reaction mixture was cooled to room
temperature and vigorously stirred in air to quench the reaction. The pre-
cipitate was removed by filtration and the filtrate was concentrated. The
same procedure for the condensation reaction and quenching was repeat-
ed once using the filtrate. C12DPAG4 was isolated by silica gel column
chromatography (chloroform/ethyl acetate/hexane 1.5:1:1.5) and prepara-
tive-scale GPC. (43 mg, 3.8 mmol, 14%). 1H NMR (400 MHz, CDCl3,
258C, TMS): d=7.65–7.62 (m, 32H), 7.47–7.45 (m, 24H), 7.04–6.37 (brm,
188H), 3.86–3.73 (m, 64H), 1.75–1.26 (brm, 640H), 0.86 ppm (m, 96H);
13C NMR (100 MHz, CDCl3, 258C, TMS): d=168.0, 167.6, 167.3, 162.3,
161.2, 159.3, 159.0, 154.1, 153.4, 152.4, 152.3, 137.5, 134.3, 134.0, 132.2,
132.0, 131.1, 130.7, 130.1, 129.9, 128.6, 128.1, 127.8, 127.7, 125.4, 124.7,
121.6, 120.6, 120.2, 113.8, 113.7, 113.4, 68.2, 68.0, 67.9, 38.7, 31.9, 30.4,
30.3, 29.62, 29.58, 29.4, 29.3, 29.2, 26.0, 22.68, 22.67, 14.1 ppm; MALDI-
TOF MS: m/z: 11345.1 [M+H]+.
Synthesis of C12DPAG2: OH-DPAG2 (74 mg, 57.5 mmol), 1-iododode-
cane (270 mg, 0.71 mmol), and K2CO3 (920 mg) were placed in a round-
bottomed flask, then DMF (5 mL) was added. The reaction mixture was
heated in an oil bath at 908C. After 14 h, the reaction mixture was fil-
tered and concentrated. C12DPAG2 was isolated by silica gel column
chromatography (chloroform/ethyl acetate/hexane 3:1:3 with 1% triethyl-
amine) and preparative-scale GPC (169 mg, 51.2 mmol, 90%). 1H NMR
(400 MHz, CDCl3, 258C, TMS): d=7.68 (d, J=8.8 Hz, 8H), 7.64 (d, J=
8.8 Hz,8H), 7.50 (d, J=8.8 Hz, 4H), 7.06 (d, J=8.3 Hz, 4H), 6.91–6.87
(m, 8H), 6.78–6.76 (m, 4H), 6.71–6.68 (m, 8H), 6.54 (d, J=8.3 Hz, 4H),
6.42 (s, 4H), 4.00–3.98 (m, 8H), 3.92 (t, J=6.3 Hz, 4H), 3.81 (t, J=
6.3 Hz, 4H), 1.80–1.77 (m, 16H), 1.59 (d, J=7.3 Hz, 4H), 1.44 (m, 12H),
1.27–1.24 (m, 128H), 0.88–0.87 ppm (m, 24H); 13C NMR (100 MHz,
CDCl3, 258C, TMS): d=167.82, 167.5, 167.44, 161.4, 161.3, 159.4, 153.9,
152.3, 147.1, 134.6, 132.4, 132.3, 131.5, 131.3, 131.2, 130.6, 130.5, 130.0,
128.0, 127.8, 121.6, 120.7, 120.3, 113.9, 113.7, 113.5, 68.1, 67.9, 31.9, 29.8,
29.63, 29.61, 29.58, 29.55, 29.44, 29.37, 29.35, 29.32, 29.23, 29.17, 26.04,
26.00, 22.66, 14.1 ppm; MALDI-TOF-MS: m/z: 2625.55 [M+H]+; ele-
mental analysis calcd (%) for C180 H252N6O8: C 82.27, H 9.67, N 3.20;
found: C 82.11, H 9.81, N 3.18.
Synthesis of C12DPAG3-G1: C12DPAG3on (140 mg, 53 mmol), 4-amino-
modified Half DPAG1 (NH2-Half DPAG1; 14.3 mg, 53 mmol) and
DABCO (450 mg, 4 mmol) were placed in
a round-bottomed flask
equipped with a three-necked adapter, then dissolved in chlorobenzene
(15 mL). Under an N2 atmosphere, the reaction mixture was heated in an
oil bath at 1258C, then chlorobenzene (5 mL) and titanium(IV) tetra-
chloride (0.1 mL, 0.8 mmol) were added by using an addition funnel. The
titanium(IV) tetrachloride solution was added dropwise. After an addi-
tional 3 h, the reaction mixture was cooled to room temperature and vig-
orously stirred in air to quench the reaction. The precipitate was re-
moved by filtration and the filtrate was concentrated. C12DPAG3-G1
was isolated by silica gel column chromatography (chloroform/ethyl ace-
tate/hexane 3:1:3 with 1% triethylamine) and preparative-scale GPC.
(84 mg, 28 mmol, 53%). 1H NMR (400 MHz, CDCl3, 258C, TMS): d=
7.69–6.41 (brm, 70H), 4.01–3.69 (m, 16H), 1.80–1.64 (m, 16H), 1.40–1.29
(m, 144H), 0.88–0.87 ppm (m, 24H); 13C NMR (100 MHz, CDCl3, 258C,
TMS): d=168.4, 168.3, 167.9, 167.7, 167.5, 161.4, 159.4, 159.2, 154.3,
154.1, 152.7, 151.8, 147.2, 146.6, 140.0, 136.4, 134.4, 134.5, 132.3, 132.1,
131.5, 131.3, 131.2, 130.7, 130.3, 130.2, 130.0, 129.7, 129.6, 129.3, 128.4,
128.0, 127.9, 127.8, 121.9, 121.2, 120.8, 120.6, 120.3, 113.9, 113.8, 113.6,
113.5, 68.1, 67.9, 31.9, 29.63, 29.61, 29.57, 29.54, 29.4, 29.3, 29.21, 29.17,
26.0, 22.7, 14.1 ppm; MALDI-TOF MS: m/z: 2987.1 [M+H]+; elemental
analysis calcd (%) for C206H270N8O8: C 82.85, H 9.11, N 3.75; found: C
83.13, H 9.18, N 3.76.
Synthesis of C12DPAG3: OH-DPAG3 (69 mg, 24.2 mmol), 1-iododode-
cane (270 mg, 0.71 mmol), and K2CO3 (920 mg) were placed in a round-
bottomed flask, then DMF (5 mL) was added. The reaction mixture was
heated in an oil bath at 908C. After 24 h, the reaction mixture was fil-
tered and concentrated. The dodecyl DPAG3 was isolated by silica gel
column chromatography (chloroform/ethyl acetate/hexane 3:1:3) and
preparative-scale GPC (107 mg, 19.4 mmol, 80%). 1H NMR (400 MHz,
CDCl3, 258C, TMS): d=7.66 (d, J=7.3 Hz, 8H), 7.62–7.60 (m, 8H),
7.47–7.45 (m, 12H), 7.04 (d, J=7.3 Hz, 8H), 6.93–6.84 (brm, 24H), 6.77–
6.67 (m, 32H), 6.63 (d, J=8.3 Hz, 4H), 6.53 (d, J=7.3 Hz, 8H), 6.48 (d,
J=8.8 Hz, 4H), 6.44 (d, J=8.3 Hz, 4H), 6.40 (s, 4H), 3.91–3.73 (m,
32H), 1.82–1.59 (m, 32H), 1.25–1.23 (m, 288H), 0.87 ppm (t, J=3.7 Hz,
48H); 13C NMR (100 MHz, CDCl3, 258C, TMS): d=168.2, 167.8, 167.6,
167.5, 167.1, 162.4, 161.4, 159.4, 159.2, 154.3, 154.2, 153.9, 152.6, 152.3,
151.9, 146.9, 134.2, 132.4, 132.2, 131.3, 131.2, 130.8, 130.5, 130.2, 130.0,
129.8, 127.9, 127.8, 121.8, 120.8, 120.3, 113.93, 113.88, 113.79, 113.6, 68.2,
68.1, 67.8, 31.9, 31.7, 29.63, 29.61, 29.58, 29.55, 29.4, 29.3, 29.2, 26.0, 22.7,
14.1 ppm; MALDI-TOF MS: m/z: 5534.6 [M+H]+; elemental analysis
calcd (%) for C380H516N14O16: C 82.44, H 9.39, N 3.54; found: C 82.35, H
9.35, N 3.51.
Synthesis of C12DPAG3-G2: C12DPAG3on (800 mg, 293 mmol), NH2-
Half DPAG2 (185 mg,293 mmol) and DABCO (450 mg, 4 mmol) were
placed in a round-bottomed flask equipped with a three-necked adapter,
then dissolved in chlorobenzene (30 mL). Under an N2 atmosphere, the
reaction mixture was heated in an oil bath at 1258C, then chlorobenzene
(5 mL) and titanium(IV) tetrachloride (0.1 mL, 0.8 mmol) were added by
using an addition funnel. The titanium(IV) tetrachloride solution was
added dropwise. After an additional 3 h, the reaction mixture was cooled
to room temperature and vigorously stirred in air to quench the reaction.
The precipitate was removed by silica filtration and the filtrate was con-
centrated. C12DPAG3-G2 was isolated by silica gel column chromatogra-
phy (chloroform/ethyl acetate/hexane 3:1:3 with 1% triethylamine) and
preparative-scale GPC. (717 mg, 214 mmol, 73%). 1H NMR (400 MHz,
CDCl3, 258C, TMS): d=7.79–6.48 (brm, 88H), 3.97–3.85 (m, 16H), 1.83–
1.74 (m, 16H), 1.50–1.33 (m, 144H), 0.93 ppm (d, J=6.8 Hz, 24H);
Synthesis of C12DPAG3on: OH-DPAG3on (530 mg, 0.38 mmol), 1-iodo-
dodecane (1414 mg, 4.77 mmol), and K2CO3 (920 mg) were placed in a
round-bottomed flask, then DMF (5 mL) was added. The reaction mix-
ture was heated in an oil bath at 908C. After 14 h, the reaction mixture
was filtered and concentrated. C12DPAG3on was isolated by silica gel
column chromatography (chloroform/ethyl acetate/hexane 3:1:3 with 1%
triethylamine) and preparative-scale GPC. (920 mg, 0.34 mmol, 88%).
1H NMR (400 MHz, CDCl3, 258C, TMS): d=7.67–7.59 (m, 12H), 7.52 (d,
J=7.8 Hz, 4H), 7.06 (d, J=6.3 Hz, 4H), 6.93–6.89 (m, 16H), 6.76–6.73
(m, 16H), 6.57 (d, J=6.8 Hz, 4H), 3.95–3.89 (m, 16H), 1.78–1.71 (m,
16H), 1.44–1.26 (m, 144H), 0.87 ppm (t, J=2.9 Hz, 24H); 13C NMR
Chem. Eur. J. 2011, 17, 800 – 809
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
807